For U.S. healthcare professionals
The clinical case for personalized multi-ingredient nasal therapy.
Evidence, published data, and the clinicians behind Allermi. Choose your specialty to see how the approach fits your patients.
Physician-authored and reviewed
Three specialties, one evidence base
Enter through your specialty.
The credibility behind it
Real-world scale, named clinicians, published data.
- 100,000+
- patients treated
- Company data
- 4.72 / 5
- across 15,000+ reviews
- Verified reviews
- 30+ years
- of clinical refinement
- Founder tenure
Figures reflect Allermi's overall patient experience and are presented alongside the peer-reviewed literature on each specialty track. Allermi is compounded from individually FDA-approved ingredients under 503A and is patient-specific. The combination itself is not FDA-approved.